Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 29, 2010
Educational forum includes lab training sessions and online community for urogynecologists, urologists and surgical gynecologists
-
Apr 27, 2010
Agreement relates to product advisories issued in 2005, before Boston Scientific acquired Guidant
-
Apr 26, 2010
Company records $1.8 billion goodwill impairment charge
-
Apr 22, 2010
Major advance in guidewire technology provides exceptional torque and flexibility for coronary procedures
-
Apr 21, 2010
A live webcast and replay of the January 11, 2011 conference will be available. Learn how to tune in.
-
Apr 19, 2010
A live webcast and replay of the May 4, 2011 conference will be available
-
Apr 19, 2010
Exclusive agreement promotes access to testing solutions for female urinary incontinence
-
Apr 15, 2010Boston Scientific to Immediately Resume Distribution of COGNIS® CRT-Ds and TELIGEN® ICDs in the U.S.
Company is positioned to fully meet customer demand for COGNIS and TELIGEN within 24 hours
-
Apr 15, 2010
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31, 2010...
-
Mar 18, 2010
Company's CRT-Ds recommended for asymptomatic and mild heart failure patients
-
Mar 16, 2010
Trials to evaluate small vessel and long lesion versions of platinum chromium PROMUS® Element™ Stent System
-
Mar 15, 2010
Boston Scientific applies to FDA for expanded indications for TAXUS Express and TAXUS® Liberte® Stents in AMI patients
-
Mar 15, 2010
Analysis of the data presented at the American College of Cardiology Annual Scientific Sessions
-
Mar 15, 2010
Manufacturing process changes were not submitted for FDA approval; no indication that changes pose any risk to patient safety
-
Mar 11, 2010
First and only premounted, balloon-expandable stent approved specifically for use in iliac arteries
-
Mar 10, 2010
Clinical data presentations to include 12-month results for third-generation TAXUS® Element™ drug-eluting stent
-
Feb 23, 2010
A webcast of the March 2 session will be available. Learn how to tune in live or watch the replay
-
Feb 10, 2010
Article reported a case summary of a patient who had been implanted subcutaneously with a Cognis cardiac resynchronization therapy defibrillator
-
Feb 10, 2010
New structure, leadership team and targeted portfolio changes will focus on sales excellence and cost effectiveness
-
Feb 10, 2010
"We delivered a quarter in line with expectations," said Ray Elliott, President and CEO
-
Feb 1, 2010
Settles three patent disputes with Johnson & Johnson (J&J) that date back to 2003
-
Jan 20, 2010
The patents relate to coatings (drug and polymer) for drug-eluting stents
-
Jan 19, 2010
Boston Scientific will webcast its February 11 conference call with financial results and business highlights for Q4 and FY 2009. Learn how to tune in.
-
Jan 14, 2010
Multi-center, prospective study plans to enroll 187 patients at 11 centers worldwide over the next 18 months
-
Jan 8, 2010
Boston Scientific only company to offer choice of two distinct drugs on separate drug-eluting stent platforms